For-Profit Pharmacies Make Billions Off 340B Program Without Clear Benefit to Patients

Teaser image of top section of a PhRMA fact sheet, displaying the title text PBMs and Chain Pharmacies Make Billions Off 340B Program Without Clear Benefit to Patients

A recent Berkeley Research Group analysis explored the staggering side effects of contract pharmacy expansion on the 340B program over the past 10 years. The misguided guidance that allowed 340B entities to contract with an unlimited number of for-profit retail pharmacies ultimately allowed for-profit vendors, pharmacies and pharmacy benefit managers to exploit the program.

Teaser image of top section of a PhRMA fact sheet, displaying the title text PBMs and Chain Pharmacies Make Billions Off 340B Program Without Clear Benefit to Patients

This website uses cookies and other tracking technologies to optimize performance, preferences, usage, and statistics. By clicking “Accept All”, you consent to store on your device the cookies and other tracking technologies that require consent. You can tailor or change your preferences by clicking “Manage My Cookies”. You can check our privacy policy for more information.